Met-Enkephalin is a neuropeptide that belongs to the enkephalin family of endogenous opioid peptides. It has been extensively studied for its potential therapeutic benefits, particularly in pain management and addiction treatment.
Chemical Name: L-Tyrosyl-L-methionine Molecular Formula: C15H20N2O3S Formula Weight: 308.39 g/mol CAS No: 58569-55-4
Top Ten Keywords from Google and Synonyms:
Synonyms:
Health Benefits of this Product: Met-Enkephalin has been shown to have several health benefits, particularly in the area of pain management. As an opioid peptide, it acts on opioid receptors in the brain and peripheral tissues, reducing sensitivity to painful stimuli and providing pain relief.
In addition to its analgesic effects, Met-Enkephalin may also have potential applications in addiction treatment. By binding to opioid receptors, it can reduce cravings and withdrawal symptoms associated with opioid addiction.
Potential Effects: Met-Enkephalin acts primarily on mu-opioid receptors in the brain and peripheral tissues, providing pain relief and reducing sensitivity to painful stimuli. It may also have effects on other neurotransmitter systems, such as dopamine and serotonin, which are involved in regulating mood and emotions.
Product Mechanism: Met-Enkephalin works by binding to mu-opioid receptors in the brain and peripheral tissues, reducing the transmission of pain signals and other sensory information to the brain. Additionally, it may enhance the release of neurotransmitters such as dopamine and serotonin, which can provide feelings of relaxation and well-being.
Safety: Met-Enkephalin appears to be safe when used at appropriate doses. However, as with any medication, it may cause adverse effects in some individuals. Additionally, because it is an opioid peptide, there is a risk of dependence and addiction if used improperly.
Side Effects: The most common side effects of Met-Enkephalin include nausea, dizziness, and sedation. Rarely, it may cause more serious adverse effects, such as respiratory depression or cardiac arrest.
Dosing Information: The optimal dose of Met-Enkephalin has not yet been established. However, studies in animals have used doses ranging from 0.01 to 10 mg/kg, depending on the desired effect and route of administration. More research is needed to determine the optimal dosing regimen for humans.
Conclusion: Met-Enkephalin is a promising neuropeptide that has potential applications in pain management and addiction treatment. Its analgesic and opioid effects make it a potentially valuable therapeutic agent for these conditions. However, further research is needed to fully understand its mechanisms of action, safety profile, and optimal dosing regimen.
